Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial - placebo-controlled, double-blind extension of phase III trial

By Djavan B.   Shariat S.   Fakhari M.   Ghawidel K.   Seitz C.   Partin A.W.   Roehrborn C.G.   Marberger M.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 251-259

Elsevier

Access to resources Recommend Favorite

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? - results of a randomized, double-blind, placebo-controlled clinical trial

By Yang X.J.   Lecksell K.   Short K.   Gottesman J.   Peterson L.   Bannow J.   Schellhammer P.F.   Fitch W.P.   Hodge G.B.   Parra R.   Rouse S.   Waldstreicher J.   Epstein J.I.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 696-700

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies

By Roehrborn C.G.   Siegel R.L.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 406-415

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite